Immunohistochemical expression of p16 in carcinoma ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types)

Bassel Tarakji, Mohammed Alsakran Altamimi, Kusai Baroudi, Mohammad Z. Nassain, Faris Q. Alenzi

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Objective: This study was aimed at characterizing alterations in the immunohistochemical expression of p16 in carcinoma ex-pleomorphic adenomas. Study Design: A selected series of 27 cases of carcinoma ex-pleomorphic adenomas were examined. R esults: The results showed that p16 expression in non tumour duct cells was strongly positive nuclear staining in 23 (85%) cases out of 27 cases, that 3 (11.1%) had moderate staining, and that 1 (3.7%) had weak staining. p16 expression in carcinoma ex-pleomorphic adenomas was indicated as a negative nuclear staining in 22 (81.4%) cases out of 27cases, and 5 (18.5%) cases expressed moderate staining. C onclusion: This study suggests that alteration of p16 expression is detected in carcinoma ex-pleomorphic adenomas. p16 has a role in development of carcinoma ex-pleomorphic adenomas.

Original languageEnglish
Pages (from-to)3054-3056
Number of pages3
JournalJournal of Clinical and Diagnostic Research
Volume7
Issue number12
DOIs
StatePublished - 15 Dec 2013

Keywords

  • CDKN2 gene
  • p16 expression

Fingerprint

Dive into the research topics of 'Immunohistochemical expression of p16 in carcinoma ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types)'. Together they form a unique fingerprint.

Cite this